Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001240 · ClinicalTrials.gov registry record
Evaluating Patients With Abnormal Levels of Gastric Acid
A clinical trial of Gastrinoma and Achlorhydria, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 1
- Study location
NCT00001240 is a study of Gastrinoma and Achlorhydria that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The trial reports 1 study location across 1 state.
The verdict
NCT00001240, a study of Gastrinoma and Achlorhydria, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasogastric suctioning, where a thin plastic tube is passed from the nose to the stomach. Depending on the patient's present condition further diagnostic testing may be required to achieve a diagnosis.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 1989-01 |
| Est. Completion | 2004-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001240
The ClinicalTrials.gov registry entry for NCT00001240 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastrinoma appearing as the primary indexed condition, and to 0 interventions.
NCT00001240 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001240 about?
NCT00001240 is a clinical study titled "Evaluating Patients With Abnormal Levels of Gastric Acid". This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasoga...
What is the current status of trial NCT00001240?
This trial is currently completed. The study started on 1989-01. Estimated completion is 2004-01.
What conditions does trial NCT00001240 study?
This clinical trial studies the following conditions: Gastrinoma, Achlorhydria, Zollinger Ellison Syndrome.
Who is sponsoring clinical trial NCT00001240?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001240 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
COMPLETED · Phase 1
-
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.